Ziopharm Oncology
www.alaunos.comAlaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.
Read more
Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.
Read more
Employees statistics
View all employeesPotential Decision Makers
Vice President , Manufacturing and Process Development
Email ****** @****.comPhone (***) ****-****Director , Regulatory Affairs and Quality
Email ****** @****.comPhone (***) ****-****Deputy Manager
Email ****** @****.comPhone (***) ****-****Associate Director
Email ****** @****.comPhone (***) ****-****
Technologies
(22)
Reach decision makers at Ziopharm Oncology
Free credits every month!
Ziopharm Oncology FAQ
Houston, United States
Biotechnology Research
